窄谱中波紫外线联合局部序贯疗法治疗寻常性银屑病疗效观察被引量：12

导出

摘要目的评价窄谱中波紫外线(NB-UVB)联合他卡西醇软膏和丙酸氯倍他索乳膏局部序贯疗法治疗寻常性银屑病的疗效。方法 82例寻常性银屑病患者随机分为联合组(NB-UVB照射联合局部序贯疗法)42例,NB-UVB组(单纯照射NB-UVB)40例,以银屑病面积和严重度指数(PASI)评价疗效。结果治疗2周时两组有效率比较,差异无统计学意义(P>0.05);治疗4周和8周时两组有效率比较,差异有统计学意义(P<0.05)。对治疗有效者半年后随访,联合组有5例复发,NB-UVB组有12例复发,差异有统计学意义(P<0.01)。结论 NB-UVB联合他卡西醇和丙酸氯倍他索局部序贯疗法治疗寻常性银屑病,疗效确切,复发率低。

作者殷文浩许玲谭宇辉陈怿朱宇翔曹庆科

机构地区浙江省嘉兴市第一医院

出处《中国中西医结合皮肤性病学杂志》 CAS 2011年第2期109-110,共2页 Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine

关键词寻常性银屑病窄谱中波紫外线他卡西醇丙酸氯倍他索序贯疗法

分类号 R758.63 [医药卫生—皮肤病学与性病学]

引文网络
相关文献

参考文献5

1满孝勇,郑敏.银屑病的治疗[J].中华皮肤科杂志,2006,39(3):174-177. 被引量：18
2Schmitt.J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis [J]. Dermatology, 2005, 210: 194-199.
3Luo S, Zheng Y, Peng Z, et al. Effects of narrow-band ultraviolet B and tazarotene therapy on keratinocyte proliferation and TIG3 expression [J]. J Dermatol, 2008, 35: 651-657.
4Lecha M, Mirada A, L6pez S, et al. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience[J]. J Eur Aead Dermatol Venereol, 2005, 19: 414-4t7.
5陈琪枫,冯信忠,温海,章伟,顾军.他卡西醇软膏联合丙酸氯倍他索软膏治疗寻常性银屑病[J].中华皮肤科杂志,2004,37(11):678-678. 被引量：3

二级参考文献20

1Feldman SR,Clark AR,Venkat AP,et al.The self-administered psoriasis area and severity index provides an objective measure of psoriasis severity.Br J Dermatol,2005,152:382-383.
2Feldman SR,Krueger GG.Psoriasis assessment tools in clinical trials.Ann Rheum Dis,2005,64 Suppl 2:ii65-73.
3Krueger G,Ellis CN.Psoriasis--recent advances in understanding its pathogenesis and treatment.J Am Acad Dermatol,2005,53 (1Suppl 1):S94-100.
4Finlay AY.Current severe psoriasis and the rule of tens.Br J Der matol,2005,152:861-867.
5Schon MP,Boehncke WH.Psoriasis.N Engl J Med,2005,352:1899-1912.
6Krueger G,Ellis CN.Psoriasis--recent advances in understanding its pathogenesis and treatment.J Am Acad Dermatol,2005,53 (1 Suppl 1):S94-100.
7Bos JD,de Rie MA,Teunissen MB,et al.Psoriasis:dysregulation of innate immnnity.Br J Dermatol,2005,152:1098-1107.
8Lebwohl M.A clinician′ s paradigm in the treatment of psoriasis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S59-69.
9Gottlieb AB.Therapeutic options in the treatment of psoriasis and atopic dermatitis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S3-16.
10Stein L.Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.J Am Acad Dermatol,2005,53 (1 Suppl 1):S39-49.